Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Aytu Biopharma (AYTU) over the last 6 years, with Q2 2025 value amounting to $652000.0.

  • Aytu Biopharma's Tax Provisions fell 2247.32% to $652000.0 in Q2 2025 from the same period last year, while for Dec 2025 it was $530000.0, marking a year-over-year decrease of 6387.18%. This contributed to the annual value of $652000.0 for FY2025, which is 6956.12% down from last year.
  • Latest data reveals that Aytu Biopharma reported Tax Provisions of $652000.0 as of Q2 2025, which was down 2247.32% from -$122000.0 recorded in Q1 2025.
  • Aytu Biopharma's 5-year Tax Provisions high stood at $841000.0 for Q2 2024, and its period low was -$300000.0 during Q4 2024.
  • For the 4-year period, Aytu Biopharma's Tax Provisions averaged around $281300.0, with its median value being $265500.0 (2023).
  • The largest annual percentage gain for Aytu Biopharma's Tax Provisions in the last 5 years was 56746.03% (2024), contrasted with its biggest fall of 13750.0% (2024).
  • Quarter analysis of 4 years shows Aytu Biopharma's Tax Provisions stood at -$3000.0 in 2021, then soared by 26766.67% to $800000.0 in 2023, then tumbled by 137.5% to -$300000.0 in 2024, then surged by 317.33% to $652000.0 in 2025.
  • Its Tax Provisions stands at $652000.0 for Q2 2025, versus -$122000.0 for Q1 2025 and -$300000.0 for Q4 2024.